Brooks O'Neil
Stock Analyst at Lake Street
(0.87)
# 3,665
Out of 4,829 analysts
36
Total ratings
28.57%
Success rate
-19.22%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $8.71 | +129.62% | 2 | Apr 21, 2025 | |
| SRDX Surmodics | Upgrades: Buy | $43 | $26.91 | +59.79% | 4 | Mar 7, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $80.26 | +37.05% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $13.95 | +115.05% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $34.79 | +104.08% | 1 | Jan 24, 2025 | |
| MODV ModivCare | Maintains: Buy | $30 → $10 | $1.17 | +754.70% | 3 | Jan 13, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $20 → $14 | $6.97 | +100.86% | 6 | Jan 8, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $12.18 | +113.46% | 1 | Dec 19, 2024 | |
| LFMD LifeMD | Initiates: Buy | $12 | $8.26 | +45.28% | 1 | Dec 10, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $24.40 | +125.41% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $12.21 | +47.42% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.06 | +63.40% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $75 | $22.98 | +226.37% | 1 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $7.05 | +70.21% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $22.27 | +16.75% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $45 | $2.52 | +1,685.71% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $1.00 | +1,000.00% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $30.10 | +323.59% | 1 | Sep 15, 2020 |
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $8.71
Upside: +129.62%
Surmodics
Mar 7, 2025
Upgrades: Buy
Price Target: $43
Current: $26.91
Upside: +59.79%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $80.26
Upside: +37.05%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $13.95
Upside: +115.05%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $34.79
Upside: +104.08%
ModivCare
Jan 13, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $1.17
Upside: +754.70%
AVITA Medical
Jan 8, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $6.97
Upside: +100.86%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $12.18
Upside: +113.46%
LifeMD
Dec 10, 2024
Initiates: Buy
Price Target: $12
Current: $8.26
Upside: +45.28%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $24.40
Upside: +125.41%
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $12.21
Upside: +47.42%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $3.06
Upside: +63.40%
May 22, 2024
Maintains: Buy
Price Target: $60 → $75
Current: $22.98
Upside: +226.37%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $7.05
Upside: +70.21%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $22.27
Upside: +16.75%
Nov 21, 2022
Assumes: Buy
Price Target: $45
Current: $2.52
Upside: +1,685.71%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $1.00
Upside: +1,000.00%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $30.10
Upside: +323.59%